Keep the pitch, the evidence, and the unknowns separate.
Company claims remain distinguishable from official records, independent sources, private documents, and management-only assertions.
For venture capital firms
Move from founder narrative to evidence-backed conviction.
Veyris gives lean venture teams a repeatable research bench for pipeline triage, market and competitive work, founder and product diligence, traction review, investment memos, and continuous portfolio intelligence.
Venture workflowPipeline to portfolio
Investment questionIs this company, market, and round worth the next level of attention?
SourceBuild the evidence packet beyond the pitch.Market · team · product · traction
UnderwriteTest what must be true for the case to work.Economics · moat · round · returns
MonitorCarry the thesis into portfolio follow-up.Milestones · hiring · funding · risk
Faster triageGive the full pipeline a consistent first pass without turning every opportunity into a full partner sprint.
Deeper convictionReconcile market claims, customer evidence, team history, technical proof, unit economics, and round terms.
Living contextKeep the original thesis, milestones, risks, follow-ups, and new company evidence connected after investment.
Pipeline breadthScreen more opportunities without lowering the evidence standard.
Evidence depthSeparate founder claims, sourced facts, assumptions, and unresolved diligence.
Partner controlThe investment team retains judgment over every recommendation and next step.
Where Veyris fits
A repeatable diligence path from first meeting to portfolio review.
Use the depth the decision deserves, from a bounded screening brief to a full source-backed IC case.
Core workflows
Make every stage of the venture process more inspectable.
01 / TriageScore pipeline fit, surface missing evidence, and identify which opportunities have earned deeper work.Mandate fit · initial risks · next questions
02 / MarketBuild market maps, peer sets, bottom-up sizing, demand evidence, funding context, and competitive benchmarks.TAM/SAM/SOM · competitors · adoption · pricing
03 / CompanyReview founders, product, technical claims, customers, ARR quality, hiring, patents, clinical or scientific evidence, and terms.Evidence quality · gaps · reference requests
04 / PortfolioTrack milestones, funding, hiring, product progress, market movement, and thesis-breaking evidence after the decision.Watch criteria · recurring monitors · decision memory
Built for venture work
Research breadth without generic startup commentary.
Veyris routes the question through startup, technical, market, financing, and investment workflows suited to the company and stage.
Match the research route to the company.
Software, healthcare, AI infrastructure, deep tech, consumer, and other verticals receive different evidence and analytical requirements.
The investment memo becomes a working set of milestones.
Follow-ups, monitoring, portfolio context, and later review begin with the thesis and evidence already assembled.
Start with the pipeline
Bring one company—or the question your partners keep asking.
See how Veyris turns venture diligence into a source-backed, reusable decision record.